from 25 to 36 in normal individuals, while among affected individuals the range is 40 to 81 5 . Similarly, polymorphic CAG repeats in the ataxin2 gene (SCA2 locus) varies from 15 to 29 repeats among normal individuals and from 35 to 59 among affected individuals 3, 9 .
Wide global variation in relative prevalence of SCA subtypes among autosomal dominant cerebellar ataxia (ADCA) patients has been observed. SCA1 has been reported to be far more common in Russia 11 than any other SCA subtypes. Recently Takano et al 12 have reported that the general prevalence of SCA1 and SCA2 is significantly higher among white SCA pedigrees (15% and 14%, respectively) than in the Japanese (3% and 5% respectively), whereas relative prevalence of SCA3 is higher in the Japanese pedigrees (43%) than in whites (30%). Also, SCA6 appear to be less frequent in white populations (5%) than in Japanese populations (11%) respectively 12 It has been reported that SCA2 is exclusively responsible for all ataxia cases in the Indian population 13 . In a study of six Indian SCA2 pedigrees, Wadia et al 13 observed CAG repeat expansion in 14 affected family members at the SCA2 locus. All of these patients showed slow saccades and peripheral neuropathy. An inverse correlation between repeat size and age at onset was observed with repeat numbers varying from 36 to 45 repeats 13 . Similar observation has been reported by Saleem et al 14 in an independent set of 39 SCA pedigrees principally from northern India. SCA2 is also the most common form of hereditary ataxias among Korean patients 15 , constituting 12.6% of all SCA patients, followed by SCA6 (6.9%) and SCA3 (4.6%).
SCA3 is more common in Germany 16 , Brazil 17 United States 18, 19 , Portugal 20 and Japan 21 . In Portugal, expansion at SCA3/MJD locus was observed in 74% of ADCA patients, followed by expansion at SCA2 locus in 4% of patients. The investigators did not find any SCA1, SCA6 mutation 20 . Similarly, in the Japanese population, Sasaki and Tashiro 21 have observed that 24.6% of patients possessed CAG expansion at the SCA3 locus, followed by expansions at SCA6 (11.8%), SCA1 (10.5%) and SCA2 (4.4%) loci. SCA6 is the most common (5%) expansion mutation in SCA patients in the United Kingdom, followed by SCA2 22 . Expansion at the SCA6 locus is also very frequent (13%) in ADCA families of Germany 23 . Spinocerebellar ataxia type 3 (SCA3), can present with parkinsonism. However, classically, atypical features, including pyramidal and cerebellar signs, peripheral neuropathy, and/or anterior horn cell dysfunction, are also seen 24 . To our knowledge, there are no previous reports of regarding the CAG repeat in patients as well as healthy individuals in Bangladesh. In this study we present the results of DNA analysis of CAG repeats in the healthy individual and as well as patients provisionally diagnosed as Parkinson Disease (PD) in Department of Neurology, Mymensingh Medical College, Mymensingh-2200, Bangladesh.
Materials and Methods:
A sample of about 5ml blood was collected by venipuncture in EDTA tube with informed consent from the patients following approval by institutional ethics committee for genetic study from 7 healthy people and 9 patients who came to Department of Neurology, Mymensingh Medical College, Mymensingh 2200, Bangladesh. The neurological disorder along with a complete physical and/or psychological, as well as family history and demographic data (sex, age at onset, age at referral, residence) was recorded with a prescribed questionnaire by the neurologists of Mymensingh Medical College. Extraction of genomic DNA from the venous blood using FlexiGene DNA kit (Qiagen, Japan) was performed in Department of Medicine, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh. Briefly, pipetting of 7.5 ml Buffer FG1 into a 15 ml centrifuge tube and then adding of 3 ml whole blood and mixing by inverting the tube 5 times. Centrifuging for 5 min at 2000 x g in a swing-out rotor and discarding the supernatant and leaving the tube inverted on a clean piece of absorbent paper for 2 min, taking care that the pellet remains in the tube. Adding of 1.5 ml Buffer FG2, closing the tube, and vortexing immediately until the pellet is completely homogenized. Inverting the tube 3 times, placing it in a heating block or water bath, and incubate at 65 degree C for 10 min. Adding of 1.5 ml isopropanol (100%) and mixing thoroughly by inversion until the DNA precipitate becomes visible as thread or a clump and centrifuging for 3 min at 2000 x g. Discarding the supernatant and briefly invert the tube onto a clean piece of absorbent paper, taking care that the pellet remains in the tube. Adding of 1.5 ml 70% ethanol and vortex for 5 second and centrifuging for 3 min at 2000 x g. Discarding of the supernatant and leaving the tube inverted on a clean piece of absorbent paper for at least 5 min, taking care that the pellet remains in the tube. Airdrying the DNA pellet until all the liquid has evaporated and adding 300 microliter FG3, vortexing for 5 second at low speed, and dissolve the DNA by incubating for 1 hour at 65 degree C in a heating block or water bath and stored at -70 degree C until used.
The extracted DNA was stored and accumulated and then these DNA were sent to Division of Clinical Genetics, Department of Medical Genetics, Osaka University Medical School, Suita, Osaka 565 0871, Japan for PCR and further analysis. PCR amplification of the CAG repeat was performed for the SCA1, SCA2, SCA3, SCA6 loci using primers SCA1N-F1 and SCA1N-R1, SCA2-F1 and SCA2-R1, MJDF1 and MJDR1, SCA6-F1 and SCA6-R1, respectively (Table 1 ) and the condition for amplification were essentially same as described earlier 4, 6, 9, 10, 25 . PCR products were checked in 3% agarose gel and the sequencing of the suspected PCR products were performed using Genescan system (version 2.02) in an ABI-377 automated DNA sequencer. (Figure 1 ). SCA2 PCR products reveal the DNA products of about 150 bp (no. of CAG repeats=23) (Figure 2 ) except one patient that we suspected and it was sequenced and revealed 175bp (no. of CAG repeats=30) (Figure 3 ). SCA3 PCR product size of both healthy individual and patient DNA is within about 250 (no. of CAG=11) to 300 bp (no. of CAG repeats=28) except one patient which is about 320bp and its CAG repeats is about 34 (Figure 4 ). SCA6 PCR product size of both healthy individual and patient DNA is about 150bp (no. of CAG=16) ( Figure 5 ).
The polyglutamine diseases are a group of inherited neurodegenerative diseases caused by the expansion of a CAG repeat coding for glutamine in each disease-causing gene. Currently there is no effective treatment against the polyQ diseases. In Bangladesh and India are in the same geographical region and it was the same country until the year 1947 but the people are not necessarily genetically akin. In this study we had examined 7 healthy individual in Mymensingh and 9 patients who came to the neurologists of Mymensingh Medical College and were diagnosed as Parkinson Disease. The age group of all the patients were 57-80 and all the patients has the tremor and most of patients has the tendency to fall down and memory impairment. Spinocerebellar ataxia type 3 (SCA3), can present with parkinsonism. However, classically, atypical features, including pyramidal and cerebellar signs, peripheral neuropathy, and/or anterior horn cell dysfunction, are also seen 24 . The patients diagnosed as PD were both male and female and they have other complaints but all are diagnosed as PD by the neurologists in Mymensingh Medical College.
The SCA1 PCR product size of both healthy individual and patient DNA is about 250bp (no. of CAG repeats=29) and therefore revealed no difference between the healthy individual and patient DNA. The SCA2 PCR product size of both healthy individual and patient DNA is about 150bp (no. of CAG repeats=23) except no. 8 of patient sample which is about 175bp and this product was sequenced and it revealed 30 CAG repeats that is within the normal range. The SCA3 PCR product size of both healthy individual and patient DNA is within about 250 (no. of CAG repeats=11) to 300bp (no. of CAG repeats=28) except no. 9 of patient which is about 320bp and its CAG repeats no. is about 34 but not pathogenic (pathogenic range is 62-79 in India). The SCA6 PCR product size of both healthy individual and patient DNA is about 150bp (no. of CAG repeats=16) and therefore revealed no difference between the healthy individual and patient DNA.
Spinocerebellar ataxia type 3 (SCA3), can present with parkinsonism but has not been previously reported, to our knowledge from Bangladesh. However, atypical, though also levodoparesponsive, parkinsonism has been previously reported to occur in African American families, suggesting that that this phenotype is associated with African ancestry. In this regard, it is perhaps significant that all the individuals with parkinsonism have relatively low numbers of repeats (normal, 16-34; pathologic, 60-84). In families in which linkage analysis is being performed to determine a locus for autosomal dominant parkinsonism suggestive of PD, evaluation for the MJD/SCA3 mutation is indicated. In our study in Bangladesh we never recorded any CAG repeat within the pathological ranges. This is the first time from Bangladesh regarding the range of CAG repeats in patients as well as healthy individual.
